GENI vs UPWK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

GENI

57.3
AI Score
VS
GENI Wins

UPWK

26.7
AI Score

Investment Advisor Scores

GENI

57score
Recommendation
HOLD

UPWK

27score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric GENI UPWK Winner
Forward P/E 59.1716 6.6578 UPWK
PEG Ratio 0 0.9813 Tie
Revenue Growth 64.7% -8.0% GENI
Earnings Growth 0.0% 17.1% UPWK
Tradestie Score 57.3/100 26.7/100 GENI
Profit Margin -23.0% 13.5% UPWK
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY GENI

Relative Price Performance (Last 90 Days)

GENI 1M: -2.3% · 3M: -19.3% UPWK 1M: +13.2% · 3M: +12.9%

Current Technical Phase

GENI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.9%) with fading momentum, RSI 49

RSI (14): 49.2 · Price: $6.38

UPWK

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 60

RSI (14): 59.7 · Price: $9.78

Fundamentals Snapshot

Metric GENI UPWK
Market Cap — —
Forward P/E 6.0 8.8
Trailing P/E — 12.0
Revenue (TTM) — —
Revenue Growth 0.6% -0.1%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% 0.2%
EPS -0.61 0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.